Clincosm LogoSign in Get a demo

colitis, ulcerative

Showing 1 - 25 of 157
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Therapeutic Endpoint in Pediatric IBD Conditions

Not yet recruiting
  • Inflammatory Bowel Diseases
  • +2 more
  • AlgometRx Nociometer
  • (no location specified)
Sep 27, 2023

Colitis, Ulcerative Trial (JNJ-77242113, Placebo)

Not yet recruiting
  • Colitis, Ulcerative
  • (no location specified)
Sep 15, 2023

Colitis, Ulcerative Trial (Etrasimod)

Available
  • Colitis, Ulcerative
  • (no location specified)
Aug 29, 2023

Colitis, Ulcerative Trial in Cambridge (GSK4381406, Placebo, Indomethacin)

Not yet recruiting
  • Colitis, Ulcerative
  • Cambridge, United Kingdom
    GSK Investigational Site
Aug 11, 2023

Colitis, Ulcerative Trial (KSP-0243, Placebo)

Not yet recruiting
  • Colitis, Ulcerative
  • (no location specified)
Apr 14, 2023

Medicine Called Infliximab[Infliximab Biosimilar 3] in People

Not yet recruiting
  • Arthritis, Rheumatoid
  • +3 more
    • (no location specified)
    Mar 31, 2023

    Crohn Disease, Colitis, Ulcerative Trial (TEV-48574 Dose Regimen A, TEV-48574 Dose Regiment B)

    Recruiting
    • Crohn Disease
    • Colitis, Ulcerative
    • TEV-48574 Dose Regimen A
    • TEV-48574 Dose Regiment B
    • Kissimmee, Florida
      Teva Investigational Site 15357
    Feb 2, 2023

    Colitis, Ulcerative Trial in Worldwide (Ustekinumab Dose Based on BSA and Body Weight, Matching Placebo)

    Recruiting
    • Colitis, Ulcerative
    • Ustekinumab Dose Based on BSA and Body Weight
    • Matching Placebo
    • Wilmington, Delaware
    • +68 more
    Jan 31, 2023

    IBD, Colitis, Ulcerative Trial in Australia, United States (MORF-057, Placebo)

    Recruiting
    • Inflammatory Bowel Diseases
    • Colitis, Ulcerative
    • Sun City, Arizona
    • +13 more
    Jan 24, 2023

    Colitis, Ulcerative Trial (Ozanimod)

    Recruiting
    • Colitis, Ulcerative
    • Dothan, Alabama
    • +88 more
    Jan 23, 2023

    Colitis, Ulcerative Trial in Worldwide (Spesolimab IV infusion, Spesolimab SC solution for injection)

    Active, not recruiting
    • Colitis, Ulcerative
    • Spesolimab IV infusion
    • Spesolimab SC solution for injection
    • Hamden, Connecticut
    • +37 more
    Jan 23, 2023

    A Study of Vedolizumab in Adults in Real-World Practice

    Recruiting
    • Colitis, Ulcerative
    • Crohn Disease
      • Beijing, Beijing, China
      • +37 more
      Jan 17, 2023

      Colitis, Ulcerative Trial in Worldwide (Cobitolimod, Placebo)

      Completed
      Has Results
      • Colitis, Ulcerative
      • Hradec Kralove, Czechia
      • +36 more
      Dec 14, 2022

      Colitis, Ulcerative, IBD Trial in Worldwide (Placebo IV, Placebo SC, Ustekinumab IV)

      Completed
      Has Results
      • Colitis, Ulcerative
      • Inflammatory Bowel Diseases
      • Placebo IV
      • +3 more
      • Birmingham, Alabama
      • +253 more
      Jan 3, 2023

      IBD, Colitis, Ulcerative Trial in Poland, United States (MORF-057)

      Recruiting
      • Inflammatory Bowel Diseases
      • Colitis, Ulcerative
      • Miami, Florida
      • +23 more
      Dec 20, 2022

      Inflammatory Bowel Disease, Colitis, Ulcerative, Crohn Disease Trial in Groningen (LMT503, Placebo)

      Not yet recruiting
      • Inflammatory Bowel Disease
      • +2 more
      • Groningen, NZ, Netherlands
        ICON plc Company - Early Development Services
      Dec 13, 2022

      Colitis, Ulcerative Trial in Worldwide (BMS-986165, Placebo Comparator)

      Recruiting
      • Colitis, Ulcerative
      • San Diego, California
      • +25 more
      Dec 15, 2022

      Colitis, Ulcerative Trial in Amsterdam (Infliximab)

      Recruiting
      • Colitis, Ulcerative
      • Dublin, Ireland
      • +6 more
      Dec 2, 2022

      Ulcerative Colitis, Colitis, Ulcerative Trial (biological, drug, other)

      Not yet recruiting
      • Ulcerative Colitis
      • Colitis, Ulcerative
      • VE202
      • +3 more
      • (no location specified)
      Nov 29, 2022

      Colitis, Ulcerative Trial in Worldwide (LYS006, Placebo)

      Completed
      • Colitis, Ulcerative
      • Sofia, Bulgaria
      • +8 more
      Nov 22, 2022

      Colitis, Ulcerative Trial in Worldwide (Ozanimod)

      Recruiting
      • Colitis, Ulcerative
      • Phoenix, Arizona
      • +48 more
      Oct 25, 2022

      Participants Receiving Flixabi or Imraldi: a French Cohort Study

      Completed
      • Arthritis, Rheumatoid
      • +4 more
      • Caluire et Cuire, Auvergne-Rhône-Alpes, France
      • +59 more
      Oct 17, 2022

      Pattern in Moderate to Severe Inflammatory Bowel Disease in Real

      Completed
      • Colitis, Ulcerative
      • +2 more
        • Minsk, Minsk Region, Belarus
        • +35 more
        Oct 4, 2022

        Crohn Disease, Colitis, Ulcerative, Arthritis, Psoriatic Trial in Worldwide (Ustekinumab)

        Recruiting
        • Crohn Disease
        • +2 more
        • Atlanta, Georgia
        • +24 more
        Aug 17, 2022

        Colitis, Ulcerative Trial in Worldwide (Golimumab, Infliximab)

        Recruiting
        • Colitis, Ulcerative
        • San Francisco, California
        • +64 more
        Aug 17, 2022